If you have been told to have surgery because of a suspicious result on a needle biopsy, you are a candidate for cytopathology and genetic testing.
Dr. Richard Guttler is a CLIA-certified thyroid cytopathologist and a member of American Society of Cytopathologists. He is an expert on the molecular markers used to detect thyroid cancer at the genetic level.
The test (Afirma by Veracyte) looks at 143 genes that are expressed in benign nodules, meaning that this test will tell you if a nodule is benign; it does not detect cancer.
Using molecular markers, this type of genetic test will prevent tens of thousands of unnecessary thyroid surgeries. The test is 96% effective at accurately identifying a benign nodule using fine needle aspiration (FNA) cytopathology.
Another marker test done on needle washouts of nodules is specific for thyroid cancer. It measures BRAF, RET/PTC/, and other thyroid cancer markers. The name is ThyGenX by Interpace lab.RAS mutations may be seen in low grade follicular type lesions that may need only a lobectomy.
Dr. Guttler uses eROSE to assess the quality of the biopsy specimen for cellular adequacy. This includes a rapid staining of the first pass and review under the microscope. The eROSE process decreases inadequacy rates and allows for the addition of molecular markers during the biopsy if the cells look worrisome for cancer.
Dr. Guttler can perform an ultrasound-guided thyroid nodule biopsy at the Thyroid Center of Santa Monica, and all cytopathology interpretations of the biopsy are performed on-site by Dr. Guttler in our cytopathology lab. Rapid turnaround means less stress and worry while you wait for the report to come back from the lab. It also means you can receive treatment sooner.
We provide cytopathology services for patients who need:
Fine needle biopsy
Fine needle aspiration
Second opinion on a prior biopsy or surgery
Sheet of papillary thyroid cancer cells with a cloudy giant cell.
At surgery there is capsule invasion. Cytology can not DD adenoma from cancer. Single Hurthle cells >20% in a biopsy suggests a neoplasm. Just like follicular carcinoma surgery is needed for diagnosis.
The first FNA that has cells with extreme eccentric nuclei with a distinct salt and pepper look and all shapes from spindle to small cell groups and can be confused with the more common Hurthle cell neoplasm needs calcitonin studies.
Thyroid Nodules 101: Mutation studies prevent 70% from going to surgery with an indeterminate biopsy diagnosis when the FNA needle washout mutations markers and classifiers are benign.
Thyroid No Surgery for Benign Nodules 101: Mutation studies prevent 70% from going to surgery...More info
DR.Guttler’s Center was one of 9 centers in this study.Interpace Diagnostics Presents Favorable New Data at the 88th Annual Meeting of the American Thyroid Association (ATA)
DR.Guttler’s Center was one of 9 centers in this study. If your biopsy was indeterminate...More info
Thyroid No Surgery 101: Even if the thyroid nodule biopsy is suspicious for thyroid cancer, it still may be benign. Hold off surgery until molecular markers for thyroid cancer are done.It may be benign and can save you an unnecessary thyroid surgery.
Thyroid No Surgery 101: Even if the thyroid nodule biopsy is suspicious for thyroid cancer, it...More info
Thyroid No Surgery 101 Why are patients going to surgery with their thyroid nodule indeterminate biopsy results? There are DNA/RNA marker tests on the nodule that can save you from unnecessary thyroid surgery.
Thyroid No Surgery 101 Why are patients going to surgery with their thyroid nodule indeterminate...More info